ilmofosine has been researched along with dihydropyridines in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, WT; Grunicke, H; Herrmann, DB; Hofer, S; Hofmann, J; Rybczynska, M; Spitaler, M; Utz, I | 1 |
1 other study(ies) available for ilmofosine and dihydropyridines
Article | Year |
---|---|
Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Transformation, Neoplastic; Dihydropyridines; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, MDR; HeLa Cells; Humans; Phospholipid Ethers; Time Factors; Tumor Cells, Cultured | 1997 |